Novotech White Papers
-
IPF - Global Clinical Trial Landscape
5/19/2025
This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.
-
Infectious Diseases - Global Clinical Trial Landscape (2025)
5/14/2025
The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.
-
Obesity - Global Clinical Trial Landscape (2025)
5/14/2025
This report analyzes the current state of global and Asia-Pacific obesity trials, highlighting regional trends, sponsor activity, and preferred endpoints.
-
Optimizing siRNA Therapeutics: Addressing Manufacturing Complexities
3/21/2025
Discover key strategies to optimize siRNA therapeutics by addressing critical nonclinical and manufacturing challenges for a smoother path to commercialization.
-
Hepatitis B - Global Clinical Trial Landscape
3/6/2025
As Hepatitis B virus (HBV) clinical trials advance, refining therapeutic endpoints and integrating novel treatment strategies are essential to transforming Hepatitis B management.
-
Triple-Negative Breast Cancer: Global Clinical Trial Landscape
1/30/2025
With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.
-
Vaccine Clinical Trials Global Landscape Whitepaper (2024)
12/5/2024
The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.
-
Bladder Cancer Global Clinical Trial Landscape (2024)
11/12/2024
Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.
-
Cervical Cancer - Global Clinical Trial Landscape (2024)
10/15/2024
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
-
Diffuse Large B-Cell Lymphoma- Global Clinical Trial Landscape
10/15/2024
Explore the latest advancements in diffuse large B-cell lymphoma research, innovative therapies, and personalized care strategies shaping the future of treatment.